Availability: In Stock
ADDITIONAL INFORMATION FOR THIS PRODUCT
Lovex is formulated as white or white-gray or white-yellow tablets, whith plate surface, with diametric division on one side and well-structured margins.
Lovex is indicated for erectile dysfunction, including the patients with diabetes, overweight, after prostatectomia or trauma of spine. A sexual stimulation is needed to make Lovex efficient.
Lovex is contraindicated in patients with known hypersensitivity to any component of the tablet. Lovex administration to patients who are using organic nitrates either regularly and/or intermittently in any forms is contraindicated. There is no controlled clinical data on the safety or efficacy of sildenafil citrate in the following groups: patients with resting hypotension, patients with retinitis pigmentosa, patients who have suffered a myocardial infarction, stroke, or life-threatening arrhythmia within last 6 months, hepatic impairment, heredity degenerative disease.
Lovex is taken orally. Recommended dose is 50 mg, taken 1 hour before sexual activity. Depending on efficiency of treatment and tolerance, the dose can be increased to 100 mg or decreased to 25 mg. Maximal recommended dose is 100 mg. The maximal recommended frequency is once per day. In elderly, the initial recommended dose is 25 mg. Depending on efficiency of treatment and tolerance, the dose can be increased to 50 mg or 100 mg. In patients with hepatic or renal impairment the initial recommended dose is 25 mg. Depending on efficiency of treatment and tolerance, the dose can be increased to 50 mg or 100 mg. Lovex is contraindicated in persons under 18 years.
There is potential for cardiac risk of sexual activity in patients with preexisting cardiovascular disease. Prior to prescribing sildenafil citrate, physicians should carefully consider their patients on multiple antihypertensive medications. Sildenafil citrate has systematic vasodilatory properties that resulted in transient decrease in supine blood pressure, in this way Lovex potentates the hypotension effect (such as sickle cell anemia, multiple myeloma, or leukemia).
The safety of sildenafil citrate is unknown in patients with bleeding disorders and patients with active peptic ulceration. Prior to prescribe sildenafil citrate to such patients the estimation of risk and efficiency should be done.
If you are administration other medicines, you should inform your physician.
Possible side effects
Taking into consideration that during clinical studies there were reported some cases of dizziness and abnormal vision, it is recommended that patients to be attentive on reactions occurring before performing skilled tasks.
COMPOSITION: Sildenafil citrate, microcrustalline cellulose, polyvinilpirolidone, talcum, croscarmellose sodium, magnesium stearate, lactose.
Dry place, avoid direct light, temperature not exceeding 25° C.
Valid shelf life: 2 years.